ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1121

$945K Total Retail Price of All Prescriptions

Rank: 87 out of 1121

745 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 745 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 745 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 17,740 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 1,055 943 1 4
SIMVASTATIN 912 800 2 1
LEVOTHYROXINE SODIUM 841 745 3 2
OMEPRAZOLE 788 690 4 6
HYDROCODONE-ACETAMINOPHEN 747 657 S3 5 3
AMLODIPINE BESYLATE 543 495 6 5
HYDROCHLOROTHIAZIDE 497 441 7 10
FUROSEMIDE 458 421 8 7
METFORMIN HCL ER 429 363 9 47
CITALOPRAM HBR 417 396 10 18
POTASSIUM CHLORIDE 360 343 11 12
WARFARIN SODIUM 343 328 12 11
GLIMEPIRIDE 337 287 13 34
CARVEDILOL 301 286 14 20
METOPROLOL TARTRATE 299 265 15 9
POLYETHYLENE GLYCOL 3350 270 249 16 70
NAMENDA 264 264 17 53
FLUTICASONE PROPIONATE 261 212 18 36
GABAPENTIN 246 214 19 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 216 182 20 31
ATENOLOL 212 204 21 16
EXELON 211 211 22 119
TRAMADOL HCL 201 147 23 25
DONEPEZIL HCL 187 187 24 35
FENOFIBRATE 180 145 25 71
METFORMIN HCL 173 146 26 8
ESCITALOPRAM OXALATE 163 149 27 94
DIOVAN 162 133 28 45
ATORVASTATIN CALCIUM 159 150 29 15
TAMSULOSIN HCL 155 153 30 32
CLOPIDOGREL 154 142 31 27
SERTRALINE HCL 147 106 32 21
PREDNISONE 139 109 33 43
LOSARTAN POTASSIUM 139 121 33 17
RANITIDINE HCL 137 117 35 33
PRAVASTATIN SODIUM 134 114 36 14
NEXIUM 131 80 37 24
MIRTAZAPINE 121 118 38 56
CRESTOR 119 107 39 28
PLAVIX 109 105 40 42
BACLOFEN 108 45 41 131
DOXYCYCLINE HYCLATE 107 87 42 103
METOPROLOL SUCCINATE 102 101 43 23
ZOLPIDEM TARTRATE 101 89 44 19
SPIRIVA 99 88 45 49
PANTOPRAZOLE SODIUM 99 99 45 29
PAROXETINE HCL 98 92 47 58
DIGOXIN 97 97 48 59
CLONIDINE HCL 96 66 49 39
LANTUS 95 60 50 52
CIPROFLOXACIN HCL 94 82 51 57
NOVOLIN R 90 66 52 174
AZITHROMYCIN 89 72 53 44
ADVAIR DISKUS 88 84 54 64
ALLOPURINOL 85 85 55 30
GLIPIZIDE 82 72 56 84
DIVALPROEX SODIUM 81 69 57 98
LOVASTATIN 79 79 58 26
KLOR-CON M20 78 59 59 85
LANSOPRAZOLE 76 54 60 162
ROPINIROLE HCL 73 72 61 91
TORSEMIDE 72 72 62 155
AMLODIPINE BESYLATE-BENAZEPRIL 70 67 63 65
TRICOR 69 50 64 126
RISPERIDONE 69 57 64 82
OXYBUTYNIN CHLORIDE 68 51 66 128
CARBIDOPA-LEVODOPA 67 67 67 118
RAMIPRIL 66 65 68 74
MELOXICAM 66 38 68 22
LANTUS SOLOSTAR 65 52 70 109
BUSPIRONE HCL 65 52 70 114
CYMBALTA 64 41 72 50
GLYBURIDE 64 60 R 72 51
SINGULAIR 63 63 74 78
PROMETHAZINE HCL 61 46 R 75 67
SYNTHROID 60 60 76 55
CYCLOBENZAPRINE HCL 58 37 R 77 83
INSULIN SYRINGE 58 42 77 77
PROPRANOLOL HCL 58 53 77 123
THEOPHYLLINE ANHYDROUS 58 53 77 175
FLUOXETINE HCL 57 55 81 60
QUETIAPINE FUMARATE 55 50 82 75
LEVETIRACETAM 55 43 82 125
JANTOVEN 55 53 82 146
DOXAZOSIN MESYLATE 54 46 85 93
ALENDRONATE SODIUM 54 46 85 37
LOSARTAN-HYDROCHLOROTHIAZIDE 53 51 87 46
LIPITOR 53 49 87 106
FENTANYL 53 53 S2 87 100
PRAMIPEXOLE DIHYDROCHLORIDE 52 50 90 158
LEXAPRO 50 38 91 218
METHYLPREDNISOLONE 50 41 91 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.